» Articles » PMID: 20104939

Drug Burden Index and Potentially Inappropriate Medications in Community-dwelling Older People: the Impact of Home Medicines Review

Overview
Journal Drugs Aging
Specialties Geriatrics
Pharmacology
Date 2010 Jan 29
PMID 20104939
Citations 57
Authors
Affiliations
Soon will be listed here.
Abstract

Background: A significant problem in older people (aged >or=65 years) is the use of potentially inappropriate medications (PIMs), including those with sedative and anticholinergic properties. However, effective intervention strategies have yet to be identified. The Drug Burden Index (DBI) is an evidence-based tool that measures a person's total exposure to medications with sedative and anticholinergic properties and has been shown to be independently associated with impairment in cognitive and physical function.

Objective: The main aim of the study was to investigate whether Home Medicines Review (HMR) services by pharmacists for community-dwelling older people would lead to an improvement in the use of medications, as measured by a decrease in the DBI score. The study also aimed to investigate the (i) distribution of DBI scores and PIMs among older people living in the community, and (ii) impact of pharmacists' recommendations on DBI scores and PIMs.

Methods: A retrospective analysis of medication reviews was performed for 372 community-dwelling older people (aged >or=65 years) who received an HMR service from the pharmacist. The main outcome measure was the total DBI score at baseline and post-HMR. The data were also examined to determine the extent of PIM use (2003 Beers' criteria), and the number and nature of pharmacists' recommendations.

Results: Overall, medications contributing to the DBI (i.e. medications with sedative or anticholinergic properties) and PIMs were identified in 60.5% (n = 225) and 39.8% (n = 148) of the patients, respectively. Following pharmacist recommendations during the HMR service, medications contributing to the DBI were identified in 51.6% (n = 192) of the patients. A statistically significant reduction in the sum total of DBI scores for all patients was observed following pharmacists' recommendations during the HMR service (206.9 vs 157.3, p < 0.001). Pharmacists' recommendations also led to a decrease in the use of PIMs, which were identified in 28.2% (n = 105) of the patients following the HMR service.

Conclusions: When the DBI is used for evaluation, pharmacists' recommendations during HMR services, if acted upon, may effect changes in the prescribing of sedative and anticholinergic medications, thereby substantially reducing the patient's drug burden. Future studies should focus on whether such a decrease may translate into functional improvements. The study also showed a positive influence of HMR services on the prescribing of PIMs.

Citing Articles

Deprescribing anticholinergics to preserve brain health: reducing the risk of dementia through deprescribing (R2D2): study protocol for a randomized clinical trial.

Campbell N, Holden R, Gao S, Unverzagt F, Lane K, Carter A Trials. 2024; 25(1):788.

PMID: 39578926 PMC: 11583418. DOI: 10.1186/s13063-024-08618-4.


Deprescribing Anticholinergics to Preserve Brain Health: Reducing the Risk of Dementia through Deprescribing (R2D2): Study Protocol for a Randomized Clinical Trial.

Campbell N, Holden R, Gao S, Unverzagt F, Lane K, Carter A Res Sq. 2024; .

PMID: 39574889 PMC: 11581051. DOI: 10.21203/rs.3.rs-4682599/v1.


Use of the Patient Portal to Discuss Medications Among People with Dementia and Their Care Partners.

Green A, Wec A, Gleason K, Gamper M, Wu M, Wolff J J Gen Intern Med. 2024; 39(16):3164-3171.

PMID: 39354256 PMC: 11618272. DOI: 10.1007/s11606-024-09064-3.


Prevalence of Adverse Drug Reactions in Hospital Among Older Patients with and Without Dementia.

Sakiris M, Hilmer S, Sawan M, Lo S, Kelly P, Blyth F Drugs Aging. 2024; 41(10):833-846.

PMID: 39342531 PMC: 11480104. DOI: 10.1007/s40266-024-01148-3.


Drug-Related Problems and Recommendations Made during Home Medicines Reviews for Sick Day Medication Management in Australia.

Truong M, Van C, Sud K, Tesfaye W, Croker N, Seth S Medicina (Kaunas). 2024; 60(5).

PMID: 38792982 PMC: 11123247. DOI: 10.3390/medicina60050798.


References
1.
Tune L . Anticholinergic effects of medication in elderly patients. J Clin Psychiatry. 2001; 62 Suppl 21:11-4. View

2.
Page 2nd R, Ruscin J . The risk of adverse drug events and hospital-related morbidity and mortality among older adults with potentially inappropriate medication use. Am J Geriatr Pharmacother. 2007; 4(4):297-305. DOI: 10.1016/j.amjopharm.2006.12.008. View

3.
Beers M, Ouslander J, Rollingher I, Reuben D, Brooks J, Beck J . Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Intern Med. 1991; 151(9):1825-32. View

4.
Zhan C, Sangl J, Bierman A, Miller M, Friedman B, Wickizer S . Potentially inappropriate medication use in the community-dwelling elderly: findings from the 1996 Medical Expenditure Panel Survey. JAMA. 2001; 286(22):2823-9. DOI: 10.1001/jama.286.22.2823. View

5.
Krska J, Cromarty J, Arris F, Jamieson D, Hansford D, Duffus P . Pharmacist-led medication review in patients over 65: a randomized, controlled trial in primary care. Age Ageing. 2001; 30(3):205-11. DOI: 10.1093/ageing/30.3.205. View